Clinical Trial

A Prospecitve Multicenter, Observational Registry Study

Recruiting
View on ClinicalTrials.gov →
Summary
This is a prospective, multicenter, observational registry study designed to collect data to deepen the understanding of CKD therapeutics, changes in clinical practice, cardiorenal risk outcomes and differences in treatment approaches in Chinese CKD patients.
Protocol Amendment History 2 changes
critical Primary endpoint(s) modified 2026-08-14
notable Trial sites expanded: 1 -> 59 locations 2026-08-14
Trial Details
NCT Number NCT07481526
Lead Sponsor AstraZeneca
Conditions Chronic Kidney Disease
Enrollment 3,000 participants
Start Date 2026-02-27
Primary Completion 2028-12-30 (estimated)
Study Completion 2028-12-30 (estimated)
Updated on ClinicalTrials.gov 2026-08-13